STXBP3
Syntaxin-binding protein 3
Also known as: STXB3_HUMAN, UNC-18C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00186
- Gene
- STXBP3
- Ensembl
- ENSG00000116266
- Chromosome
- 1
- Canonical length
- 592 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Enables syntaxin binding activity. Involved in negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; and platelet aggregation. Located in cytosol; plasma membrane; and secretory granule. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
592 residues, UniProt reviewed canonical sequence.
>O00186|STXBP3
1 MAPPVAERGL KSVVWQKIKA TVFDDCKKEG EWKIMLLDEF TTKLLASCCK MTDLLEEGIT
61 VVENIYKNRE PVRQMKALYF ITPTSKSVDC FLHDFASKSE NKYKAAYIYF TDFCPDNLFN
121 KIKASCSKSI RRCKEINISF IPHESQVYTL DVPDAFYYCY SPDPGNAKGK DAIMETMADQ
181 IVTVCATLDE NPGVRYKSKP LDNASKLAQL VEKKLEDYYK IDEKSLIKGK THSQLLIIDR
241 GFDPVSTVLH ELTFQAMAYD LLPIENDTYK YKTDGKEKEA ILEEEDDLWV RIRHRHIAVV
301 LEEIPKLMKE ISSTKKATEG KTSLSALTQL MKKMPHFRKQ ITKQVVHLNL AEDCMNKFKL
361 NIEKLCKTEQ DLALGTDAEG QKVKDSMRVL LPVLLNKNHD NCDKIRAILL YIFSINGTTE
421 ENLDRLIQNV KIENESDMIR NWSYLGVPIV PQSQQGKPLR KDRSAEETFQ LSRWTPFIKD
481 IMEDAIDNRL DSKEWPYCSQ CPAVWNGSGA VSARQKPRAN YLEDRKNGSK LIVFVIGGIT
541 YSEVRCAYEV SQAHKSCEVI IGSTHVLTPK KLLDDIKMLN KPKDKVSLIK DELocalizationUniProt · AlphaFold · HPA
Whether an antibody against STXBP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 64 nTPM
- parathyroid gland: 40 nTPM
- kidney: 38 nTPM
- midbrain: 36 nTPM
- thyroid gland: 35 nTPM
- retina: 32 nTPM
Single-cell type
- neutrophils: 392 nCPM
- oligodendrocytes: 245 nCPM
- neutrophil progenitors: 165 nCPM
- syncytiotrophoblasts: 144 nCPM
- urothelial cells: 143 nCPM
- platelets: 136 nCPM
Immune cell
- basophil: 63 nTPM
- neutrophil: 48 nTPM
- eosinophil: 43 nTPM
- non-classical monocyte: 25 nTPM
- intermediate monocyte: 21 nTPM
- T-reg: 21 nTPM
Brain region
- white matter: 75 nTPM
- medulla oblongata: 56 nTPM
- basal ganglia: 51 nTPM
- cerebellum: 51 nTPM
- spinal cord: 46 nTPM
- midbrain: 45 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STXBP3.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 93 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- STXBP3-related disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.76
- DepMap mean gene effect
- -0.45
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- brain development
- cellular response to type II interferon
- insulin secretion
- intracellular glucose homeostasis
- intracellular protein transport
- negative regulation of calcium ion-dependent exocytosis
- negative regulation of D-glucose import
- neutrophil degranulation
- platelet aggregation
- presynaptic dense core vesicle exocytosis
- protein to membrane docking
- response to insulin
- vesicle docking involved in exocytosis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STXBP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STXBP3 as an antibody target. Whether an autoantibody or antibody against STXBP3 could matter depends on whether native STXBP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STXBP3 is annotated at the cell surface, where native STXBP3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label STXBP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...